Vantage logo

EQRX aims for biopharma Spac record

Spac redemptions are a growing concern, but the $1.8bn EQRX deal looks primed to succeed. Proving the business model will be the hard part.

Vantage logo

Why not bapineuzumab?

Like Aduhelm this long-discontinued amyloid beta MAb reduced brain beta amyloid; so have several other industry projects.